State lawmakers are relying on four main approaches to protect hospitals and pharmacies against insurance industry restrictions on 340B drug discounts, according to a forthcoming survey by Manatt Health. The most common approach is to prohibit insurers from paying hospitals and the pharmacies they contract with less for 340B drugs than drugs that are not subject to the discounts, according to Manatt Health Partner Helen Pfister. Several state lawmakers also have introduced bills that aim to stop insurers from limiting...